The treatment Hydrafacial can be performed alone or alongside another spa treatment. It begins with a skin assessment that evaluates skin condition: pigmentation spots, wrinkles, sensitivity or dehydration. With specific effects on tone evenness, radiance, blemishes and hydration, the Hydrafacial adapts to all skin types. The protocol is customisable: the peel concentration, the choice of active ingredients and tips are adjusted to specific skin needs. For combination to oily skin, it unclogs pores. For mature skin, it helps smooth wrinkles and fine lines while firming the facial contour. Sensitive and dry skin receive deep hydration, while skin prone to imperfections regain radiance and a smoother texture. This complete non-invasive treatment leaves skin clearer, brighter and revitalised. It is contraindicated in pregnant people and in those with skin lesions or highly reactive skin.
A study published in the Journal of Cosmetic Dermatology and conducted on 20 volunteers aged 34 to 56 aimed to validate the efficacy and safety of hydradermabrasion. Participants were divided into two groups (A and B). Group A underwent six hydradermabrasion sessions using a polyphenolic antioxidant serum. Sessions were spaced seven to ten days apart. Group B received the same antioxidant serum over six sessions spaced seven to ten days apart but without hydradermabrasion and with manual application. Digital photographs, skin biopsies, and skin polyphenolic antioxidant levels were recorded before and after treatment.
Results indicate that in group A, treatment increased the thickness of the epidermis, papillary dermis, and fibroblasts. The increase in papillary dermis thickness and fibroblast density suggests a heightened collagen and elastin production, key components of skin firmness and elasticity. A significant rise in polyphenolic antioxidant levels (P < 0.01) was observed, reflecting the skin’s improved ability to neutralise free radicals, the primary drivers of premature ageing. Dermal tissue was renewed with denser collagen and fibroblast structures. Clinically, fine lines, pore size, and hyperpigmentation decreased without reported complications. In contrast, group B showed no structural, biochemical, or clinical skin changes.